In contrast, patients with coexisting CNS demyelinating disease and hyperthyroidism showed significantly increased T cell responses to a panel of three LGR4 peptides, compared to all other groups (p ≤ 0.005) (Figure 1). This evidence concerns the gene LGR4 and demyelinating disease of central nervous system.